Asian Spice Could Reduce Breast Cancer Risk

Follow us on Twitter

An estimated six million women in the United States currently use hormone replacement therapy to treat the symptoms of menopause.

Taking a combined estrogen and progestin hormone replacement therapy has increased their risk of developing progestin-accelerated breast tumors note medical experts. According to the American Association for Critical Illness Insurance nearly 700,000 U.S. women will be diagnosed with cancer this year and over one-quarter will have breast cancer.

University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.

The results of the study showed that women could potentially take curcumin to protect themselves from developing progestin-accelerated tumors, researchers noted. In the study, researchers found that curcumin delayed the first appearance, decreased incidence and reduced multiplicity of progestin-accelerated tumors in an animal model.

Curcumin also prevented the appearance of gross morphological abnormalities in the mammary glands. In prior studies, University of Missouri researchers showed that progestin accelerated the development of certain tumors by increasing production of a molecule that helps supply blood to the tumor.

Written by Mindy Hartman
Los Angeles, CA
Exclusive to HULIQ.com